Unveiling the role of EBV in the onset and progression of multiple sclerosis

Recent evidence strongly implicates infection by the Epstein-Barr virus (EBV) as the trigger for development of multiple sclerosis (MS). An international research team is now gathering to unveil the role of EBV in the onset and progression of the MS disease.

Related Keywords

Norway ,Oslo ,Belgium ,Stavanger ,Rogaland ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Sweden ,United States ,Italy ,Haukeland ,Hordaland ,Stockholm ,Roma ,Lazio ,Elisabeth Kasilingam ,Karolinska Institutet ,Kjell Morten Myhr ,Universidad Pompeu Fabra ,Sapienza Universit ,Danielle Ellis ,Haukeland University Hospital ,Vestre Viken Health ,University Of Bergen ,Hospital Del Mar Research Institute ,Akershus University Hospitals ,Harvard University ,Fundacio Centre De Regulacio Genomica ,Torkildsen At Haukeland University Hospital ,Oslo University Hospital ,Haukeland University ,European Multiple Sclerosis ,Targeting Epstein Barr ,Horizon Europe ,University Hospital ,Vestre Viken Health Trust ,Raffaele Roma ,Fondazione Italiana Sclerosi Multipla Fism Onlus ,Pompeu Fabra ,Epstein Barr Virus ,Virus ,Hospital ,Multiple Sclerosis ,Research ,Clerosis ,